ECSS
BSX icon

Eurizon Capital SGR SpA’s Boston Scientific BSX Stock Holding History

Eurizon Capital SGR SpA’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9M Sell
1,210,293
-138,190
-10% -$7.5M 0.14% 131
2026
Q1 		$84.8M Buy
1,348,483
+50,550
+4% +$4.04M 0.26% 80
2025
Q4 		$124M Buy
+1,297,933
New +$127M 0.39% 59

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eurizon Capital SGR SpA's BSX Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Boston Scientific (BSX) stake by 10% in Q2 2026, selling an estimated $7.5M and leaving 1,210,293 shares worth $51.9M. The position accounts for 0.14% of the portfolio, ranked #131.

Eurizon Capital SGR SpA first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $124M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Eurizon Capital SGR SpA held 1,210,293 shares of Boston Scientific worth $51.9M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 138,190 Boston Scientific shares in Q2 2026, an estimated $7.5M.
  • Boston Scientific made up 0.14% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #131 holding.
  • Eurizon Capital SGR SpA first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Boston Scientific position peaked at $124M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.